CUVL
Clinuvel Pharmaceuticals Ltd.
There isn't enough reported data to score CUVL yet.
CUVL Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate CUVL's fundamentals.
CUVL PE Valuation
CUVL has no meaningful PE right now: it lost money over the past year.
CUVL Forward outlook
There aren't enough analyst estimates for CUVL to show an outlook.
CUVL Earnings Per Share
CUVL Quarterly Revenue
CUVL Free Cash Flow
CUVL Net Leverage
CUVL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CUVL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.6 | Neutral |
| Stochastic | 7.1 | Oversold |
CUVL's weekly RSI is 48 (neutral) and its Stochastic is 7 (oversold).
CUVL PE vs Healthcare Sector
CUVL has no meaningful PE right now: it lost money over the past year.
CUVL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.33 | 5.3% below |
| 20 week MA | $6.20 | 19% below |
CUVL is in a downtrend: it's below all two of its weekly moving averages, and 19% below its 20-week average.
CUVL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $7.05 | $5.05 | -28% |
It's down 28% so far in 2026.